[PHARMA] QoQ Quarter Result on 30-Jun-2014 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Aug-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Jun-2014 [#2]
Profit Trend
QoQ- -39.07%
YoY- 172.38%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Revenue 471,904 627,103 502,086 525,072 468,672 567,860 440,807 4.65%
PBT 38,612 37,854 24,945 24,622 38,159 33,007 13,461 102.01%
Tax -6,686 -1,233 -9,944 -8,665 -11,513 -11,740 -9,291 -19.71%
NP 31,926 36,621 15,001 15,957 26,646 21,267 4,170 288.93%
-
NP to SH 31,794 36,697 14,955 15,975 26,217 20,813 3,751 316.25%
-
Tax Rate 17.32% 3.26% 39.86% 35.19% 30.17% 35.57% 69.02% -
Total Cost 439,978 590,482 487,085 509,115 442,026 546,593 436,637 0.50%
-
Net Worth 528,173 525,351 507,124 502,293 515,022 486,672 473,402 7.57%
Dividend
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Div 18,123 31,055 20,698 10,356 10,352 16,049 7,760 76.11%
Div Payout % 57.00% 84.63% 138.41% 64.83% 39.49% 77.11% 206.90% -
Equity
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Net Worth 528,173 525,351 507,124 502,293 515,022 486,672 473,402 7.57%
NOSH 258,908 258,794 258,737 258,914 258,805 258,868 258,689 0.05%
Ratio Analysis
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
NP Margin 6.77% 5.84% 2.99% 3.04% 5.69% 3.75% 0.95% -
ROE 6.02% 6.99% 2.95% 3.18% 5.09% 4.28% 0.79% -
Per Share
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
RPS 182.27 242.32 194.05 202.80 181.09 219.36 170.40 4.59%
EPS 12.28 14.18 5.78 6.17 10.13 8.04 1.45 316.02%
DPS 7.00 12.00 8.00 4.00 4.00 6.20 3.00 76.01%
NAPS 2.04 2.03 1.96 1.94 1.99 1.88 1.83 7.51%
Adjusted Per Share Value based on latest NOSH - 258,914
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
RPS 32.74 43.51 34.84 36.43 32.52 39.40 30.58 4.65%
EPS 2.21 2.55 1.04 1.11 1.82 1.44 0.26 317.04%
DPS 1.26 2.15 1.44 0.72 0.72 1.11 0.54 76.01%
NAPS 0.3665 0.3645 0.3519 0.3485 0.3573 0.3377 0.3285 7.57%
Price Multiplier on Financial Quarter End Date
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Date 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 -
Price 6.00 4.58 4.63 4.61 4.46 4.45 4.82 -
P/RPS 3.29 1.89 2.39 2.27 2.46 2.03 2.83 10.57%
P/EPS 48.86 32.30 80.10 74.72 44.03 55.35 332.41 -72.18%
EY 2.05 3.10 1.25 1.34 2.27 1.81 0.30 260.52%
DY 1.17 2.62 1.73 0.87 0.90 1.39 0.62 52.76%
P/NAPS 2.94 2.26 2.36 2.38 2.24 2.37 2.63 7.71%
Price Multiplier on Announcement Date
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Date 18/05/15 23/02/15 21/11/14 21/08/14 14/05/14 24/02/14 19/11/13 -
Price 6.91 5.28 4.45 4.62 4.70 4.29 4.72 -
P/RPS 3.79 2.18 2.29 2.28 2.60 1.96 2.77 23.26%
P/EPS 56.27 37.24 76.99 74.88 46.40 53.36 325.52 -69.00%
EY 1.78 2.69 1.30 1.34 2.16 1.87 0.31 220.99%
DY 1.01 2.27 1.80 0.87 0.85 1.45 0.64 35.58%
P/NAPS 3.39 2.60 2.27 2.38 2.36 2.28 2.58 19.98%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment